PF-Atlas › Clinical Trials › NCT06262282
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
mycobacteriophage · Not specified
Registry ID
NCT06262282
Phase
Not specified
Status
Enrolling by invitation
Drug / intervention
mycobacteriophage
Sponsor
National Jewish Health
Start
2024-02-05
About this trial
mycobacteriophage is evaluated in NCT06262282, a idiopathic pulmonary fibrosis study sponsored by National Jewish Health. Current status: Enrolling by invitation.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06262282 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.